| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.18 | 3e-06 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.19 | 0.0003 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0003 |
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0003 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0003 |
| mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0005 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | -0.14 | 0.001 |
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.002 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.15 | 0.003 |